Skip to main content
. 2017 Jul 17;46(4):313–323. doi: 10.1007/s00240-017-0998-6

Table 3.

Change in plasma oxalate concentration from baseline to week 24

Plasma oxalate (μmol/L)
OC3 Placebo
Absolute values % change to baseline Absolute values % change to baseline
Baselinea
 n 21 13
 Mean (SD) 13.92 (7.578) 9.68 (4.024)
 Median 11.00 8.90
 Min, Max 7.3, 35.0 4.5, 18.5
Week 24a
 n 21 21 13 13
 Mean (SD) 12.38 (7.79) −12.20 (22.55) 9.82 (6.877) 5.23 (68.53)
 Median 9.00 −14.42 6.70 −8.45
 Min, Max 3.3, 35.0 −64.5, 30.3 3.0, 24.1 −60.3, 192.3
 Mean treatment difference −17.43
 95% confidence interval −50.21, 15.34
 p valueb 0.75

SD standard deviation

a Numbers were derived from a post hoc analysis after the finalisation of the Clinical Study Report (CSR)

b p value was derived after a Wilcoxon-Mann–Whitney-test